Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
B. Mühlemann, J. Trimpert, F. Walper…·C. Drosten
The paper uses hamster sera from variant-specific infections to map antigenic differences among SARS-CoV-2 variants, revealing significant antigenic variation among Omicron subvariants.
S. H. Wilks, B. Muhlemann, X. Shen…·D. J. Smith
The paper uses antigenic cartography to analyze cross-reactivity among SARS-CoV-2 variants and human sera, identifying amino acid substitutions and immunodominance patterns affecting immune escape and vaccine efficacy.
D. Niemeyer, S. Schroeder, K. Friedmann…·C. Drosten
The paper shows that B.1.1.7 and B.1.617.2 SARS-CoV-2 variants have a replication advantage over B.1 in ACE2-deficient lung cells, suggesting reliance on alternative cellular factors.
S. M. Reincke, M. Yuan, H.-C. Kornau…·J. Kreye
SARS-CoV-2 Beta variant infection generates lineage-specific antibodies and cross-reactive antibodies with neutralizing activity against wild-type and other variants.
J. Kreye, S. M. Reincke, H.-C. Kornau…·N. Osterrieder
This study identifies a potent SARS-CoV-2 neutralizing antibody that protects hamsters from infection and lung damage.